CompoAtlas

Women + 40 Greens

Testo originale in francese.

Prodotto naturale per la salute autorizzato in Canada

Se questo prodotto fosse venduto in Francia

Si calcola una quantità giornaliera solo per una posologia orale esplicita per adulti, espressa al giorno e in un’unità solida corrispondente alla forma del prodotto. Unità ambigue, liquidi, polveri e dosi pediatriche non vengono estrapolati. Una quantità non calcolata non viene confrontata con i limiti di dose. Questa analisi non costituisce un’autorizzazione alla vendita in Francia né una valutazione di sicurezza o efficacia.

Composizione

Ingrediente medicinale e fontePer unità posologica, secondo la fonteMassimo giornaliero, adulto
Beta-D-Fructofuranosidase

Fonte : Aspergillus niger

Potenza : 125 FCC SU Invertase

12,5 mgNon calcolata
Beta-D-Fructofuranosidase

Fonte : Isolat

Potenza : 125 FCC SU Invertase

12,5 mgNon calcolata
1,4-alpha-D-Glucane glucohydrolase

Fonte : Isolat

Potenza : 2,5 FCC AGU Glucoamylase

5,6 mgNon calcolata
1,4-alpha-D-Glucane glucohydrolase

Fonte : Aspergillus niger

Potenza : 2,5 FCC AGU Glucoamylase

5,6 mgNon calcolata
Taraxacum officinale

Fonte : Racine

12 mgNon calcolata
chlorophylle

Fonte : alfalfa

5 mgNon calcolata
Vaccinium macrocarpon

Fonte : Fruit

4 mgNon calcolata
Lécithine

Fonte : Huile de soja

1.700 mgNon calcolata
1,5-alpha-L-arabinane arabinanohydrolase

Fonte : Isolat

Potenza : 450 FCC HCU

5 mgNon calcolata
1,5-alpha-L-arabinane arabinanohydrolase

Fonte : Aspergillus niger

Potenza : 450 FCC HCU

5 mgNon calcolata
3-(1-3,1-4)-bêta-D-glucan 3(4)-glucanohydrolase

Fonte : Isolat

Potenza : 2 FCC BGU

5 mgNon calcolata
3-(1-3,1-4)-bêta-D-glucan 3(4)-glucanohydrolase

Fonte : Aspergillus niger

Potenza : 2 FCC BGU

5 mgNon calcolata
Lactobacillus delbrueckii subsp. bulgaricus

Fonte : Lactobacillus delbrueckii subsp. Bulgaricus

Potenza : 0,125 Milliards d'UFC

2,5 mgNon calcolata
Lactobacillus delbrueckii subsp. bulgaricus

Fonte : ATCC SD5589

Potenza : 0,125 Milliards d'UFC

2,5 mgNon calcolata
Lactobacillus rhamnosus

Fonte : Lactobacillus rhamnosus

Potenza : 1 Milliards d'UFC

5 mgNon calcolata
Lactobacillus rhamnosus

Fonte : ATCC SD5217

Potenza : 1 Milliards d'UFC

5 mgNon calcolata
Beta vulgaris

Fonte : Racine

2 mgNon calcolata
Astragalus membranaceus

Fonte : Racine

5 mgNon calcolata
Citrus limon

Fonte : Pelure (fruit)

38 mgNon calcolata
Vaccinium corymbosum

Fonte : Fruit

2 mgNon calcolata
Vitis vinifera

Fonte : Graine(s)

Potenza : 8,5 mg OPC's

10 mgNon calcolata
Carica papaya

Fonte : Fruit

2 mgNon calcolata
Trifolium pratense

Fonte : Fleur

15 mgNon calcolata
Withania somnifera

Fonte : Racine

26 mgNon calcolata
Hordeum vulgare

Fonte : Plante

2.115 mgNon calcolata
Hordeum vulgare

Fonte : En entier

2.115 mgNon calcolata
Brassica oleracea var. italica

Fonte : Plante entière

133 mgNon calcolata
4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase

Fonte : Aspergillus oryzae

Potenza : 315 FCC CU

7,9 mgNon calcolata
4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase

Fonte : Isolat

Potenza : 315 FCC CU

7,9 mgNon calcolata
Curcuma longa

Fonte : Racine

20 mgNon calcolata
Cinnamomum burmannii

Fonte : Écorce

10 mgNon calcolata
Protéase fongique

Fonte : Aspergillus niger

Potenza : 1.250 FCC HUT

12,5 mgNon calcolata
Protéase fongique

Fonte : Isolat

Potenza : 1.250 FCC HUT

12,5 mgNon calcolata
Bifidobacterium bifidum

Fonte : ATCC SD5215

Potenza : 0,25 Milliards d'UFC

0,5 mgNon calcolata
Bifidobacterium bifidum

Fonte : Bifidobacterium bifidum

Potenza : 0,25 Milliards d'UFC

0,5 mgNon calcolata
Pinus strobus

Fonte : Écorce

10 mgNon calcolata
Pectin pectylhydrolase

Fonte : Isolat

Potenza : 10 Endo-PG Pectinase

6,4 mgNon calcolata
Pectin pectylhydrolase

Fonte : Aspergillus niger

Potenza : 10 Endo-PG Pectinase

6,4 mgNon calcolata
papaïne

Fonte : Carica papaya

Potenza : 1.296.000 USP units Papain

54 mgNon calcolata
Lactobacillus acidophilus

Fonte : Lactobacillus acidophilus

Potenza : 1,5 Milliards d'UFC

11,25 mgNon calcolata
Lactobacillus acidophilus

Fonte : ATCC SD5212

Potenza : 1,5 Milliards d'UFC

11,25 mgNon calcolata

Ingredienti non medicinali

Feuille de persil, Saveur de feuille de Brassica oleracea var. capitata, Vanille (de Tahiti), Pomme, Fraise, épinard, tomate, Poudre de racine de carotte, Feuille de stevia rebaudiana, Fruit d'acérola

Dosi raccomandate in Canada

PopolazioneEtàQuantità per assunzioneFrequenza
AdultesNon précisée1 Mesures1 Tous les jours

Usi autorizzati in Canada

Provides antioxidants for the maintenance of good health. Provides live microorganisms that contribute to healthy gut flora. Helps to support liver function.

Testo originale in inglese.

Un uso autorizzato in Canada non è un’indicazione sulla salute autorizzata nell’Unione europea. Consulti il registro delle indicazioni sulla salute.

Avvertenze in Canada

Cautions and Warnings : For Adult use only. Consult a health care practitioner prior to use if you have any type of acute infection; have gastrointestinal lesions/ulcers, are taking anticoagulant agents, anti-inflammatory agents, other enzyme products or antibiotics or before having surgery; if you have allergy to latex or fruits (such as avocado, banana, chestnut, passion fruit, fig, melon, mango, kiwi, pineapple, peach and tomato); if you have nausea, fever, vomiting, bloody diarrhea or severe abdominal pain or if symptoms of digestive upset occur, worsen or persist beyond 3 days. Consult a health care practitioner prior to use if you have diabetes, a liver disorder or develop symptoms of liver trouble (such as abdominal pain, dark urine or jaundice); if you have an iron deficiency; if you have gallstones or a bile duct obstruction, stomach ulcers or excess stomach acid, or if symptoms persist or worsen; if you have a history of kidney stones; if you are taking cardiac glycosides such as digitalis/digoxin. Consumption with alcohol, other drugs or natural health products with sedative properties is not recommended.

Testo originale in inglese.

Contra-Indications : Do not use if you have high blood pressure; if you have liver or gall bladder disorders, and/or bowel obstruction; if you are pregnant or breastfeeding; if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment); or if you are using health care products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils Vitamin E) as these may increase the risk of spontaneous bleeding. Discontinue use if you develop symptoms of liver trouble. Do not use this product if you are attempting to conceive.

Testo originale in inglese.

Known Adverse Reactions : Hypersensitivity/allergy has been known to occur, in which case discontinue use. Nausea, vomiting, and diarrhea have been known to occur, in which case discontinue use and consult a health care practitioner. Laxative effect may occur, in which case discontinue use. This product has come into contact with dairy and soy proteins; if you have a gluten, milk or soy allergy, do not use this product.

Testo originale in inglese.

Scheda del prodotto

Titolare
FoodState Incorporated
NPN o DIN-HM
80041613
Stato
Licenza non attiva
Data della licenza
11 aprile 2013
Data di revisione
Non indicata
Forma
Poudre
Via di somministrazione
Orale
Tipo di domanda
Non traditionnelle

Fonte

Scheda ufficiale Health Canada, licenza 80041613

Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze, consultato il 27 ottobre 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Testo originale in inglese.

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Testo originale in francese.

La formula venduta in Europa con lo stesso nome può essere diversa. Queste informazioni non sostituiscono il parere di un medico o farmacista.

Avvertenze ufficiali (Health Canada)

Health Canada pubblica avvertenze su questi ingredienti:

  • Vaccinium macrocarpon
    Leggere l'avvertenza, quando si applica e gli studi citati

    Testo originale ufficiale in inglese.

    CRANBERRY - VACCINIUM MACROCARPON

    Via di somministrazione: Oral

    Precauzioni e avvertenze

    Condizione di applicazione: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).

    Fonti citate da Health Canada (2)
    • Gettman MT, Ogan K, Brinkley LJ, Adams-Huet B, Pak CYC, Pearle MS. Effect of cranberry juice consumption on urinary stone risk factors. The Journal of Urology 2005;174(2):590-594. PubMed Studio randomizzato
    • Terris MK, Issa MM, Tacker JR. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 2001;57(1):26-29. PubMed

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).

    Fonti citate da Health Canada (4)
    • Aston JL, Lodolce AE, Shapiro NL. Interaction between warfarin and cranberry juice. Pharmacotherapy 2006;26(9):1314-1319. PubMed
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Grant P. Warfarin and cranberry juice: an interaction? The Journal of Heart Valve Disease 2004;13(1):25-26. PubMed Caso clinico
    • Rindone JP, Murphy TW. Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding. American Journal of Therapeutics 2005;13(3):283-284.

    Condizione di applicazione: (Recurrent) urinary tract infection.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Monografia di Health Canada del 27 marzo 2026

    DRIED CRANBERRY JUICE

    Via di somministrazione: Oral

    Precauzioni e avvertenze

    Condizione di applicazione: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).

    Fonti citate da Health Canada (2)
    • Gettman MT, Ogan K, Brinkley LJ, Adams-Huet B, Pak CYC, Pearle MS. Effect of cranberry juice consumption on urinary stone risk factors. The Journal of Urology 2005;174(2):590-594. PubMed Studio randomizzato
    • Terris MK, Issa MM, Tacker JR. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 2001;57(1):26-29. PubMed

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).

    Fonti citate da Health Canada (4)
    • Aston JL, Lodolce AE, Shapiro NL. Interaction between warfarin and cranberry juice. Pharmacotherapy 2006;26(9):1314-1319. PubMed
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Grant P. Warfarin and cranberry juice: an interaction? The Journal of Heart Valve Disease 2004;13(1):25-26. PubMed Caso clinico
    • Rindone JP, Murphy TW. Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding. American Journal of Therapeutics 2005;13(3):283-284.

    Condizione di applicazione: (Recurrent) urinary tract infection.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Monografia di Health Canada del 27 marzo 2026

  • Lécithine
    Leggere l'avvertenza, quando si applica e gli studi citati
  • Astragalus membranaceus
    Leggere l'avvertenza, quando si applica e gli studi citati

    Testo originale ufficiale in inglese.

    ASTRAGALUS - ASTRAGALUS MEMBRANACEUS

    Via di somministrazione: Oral

    Precauzioni e avvertenze

    Condizione di applicazione: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).

    Fonti citate da Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Astragalus Root. Santa Cruz (CA): American Herbal Pharmacopoeia; 1999.

    Controindicazioni

    Condizione di applicazione: Traditional Chinese Medicine.

    Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).

    Fonti citate da Health Canada (2)
    • Bensky D, Clavey, Stöger E, Gamble A. Chinese Herbal Medicine: Materia Medica. 3rd edition. Seattle (WA): Eastland Press, Incorporated; 2004.
    • Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.

    Monografia di Health Canada del 30 maggio 2025

  • Vaccinium corymbosum
    Leggere l'avvertenza, quando si applica e gli studi citati

    Testo originale ufficiale in inglese.

    Blueberry

    Via di somministrazione: Oral

    Precauzioni e avvertenze

    Si applica ai prodotti: providing 5 grams or more of total dried fruit, per day; Products providing 37.5 grams or more of total fresh fruit, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (ASHP 2005; Franco et al. 2004; IOM 2001; Hansten et al. 1997).

    Fonti citate da Health Canada (4)
    • ASHP 2005: American Society of Health-System Pharmacists. American Hospital Formulary Service (AHFS) Drug Information. Philadelphia (PA): Lippincott Williams and Wilkins; 2005.
    • Franco V, Polanczyk CA, Clausell N, Rohde LE. Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. The American Journal of Medicine 2004;166(10):651-656. PubMed Studio randomizzato
    • Hansten PD, Horn JR, editors. Drug Interactions Analysis and Management. Vancouver (WA): Applied Therapeutics Inc.; 1997.
    • IOM 2001: Institute of Medicine. Panel on Micronutrients, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington (DC): National Academies Press; 2001.

    Monografia di Health Canada del 29 agosto 2025

  • Withania somnifera
    Leggere l'avvertenza, quando si applica e gli studi citati

    Testo originale ufficiale in inglese.

    ASHWAGANDHA - WITHANIA SOMNIFERA

    Via di somministrazione: Oral

    Precauzioni e avvertenze

    Condizione di applicazione: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condizione di applicazione: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).

    Fonti citate da Health Canada (3)
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
    • Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).

    Fonti citate da Health Canada (3)
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
    • McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
    • Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.

    Monografia di Health Canada del 28 febbraio 2025

  • Curcuma longa
    Leggere l'avvertenza, quando si applica e gli studi citati

    Testo originale ufficiale in inglese.

    TURMERIC - CURCUMA LONGA - Oral

    Via di somministrazione: Oral (ESCOP 2003; Blumenthal et al. 2000)

    Precauzioni e avvertenze

    Condizione di applicazione: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (ESCOP 2003; Brinker 2001; McGuffin et al. 1997).

    Fonti citate da Health Canada (2)
    • ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.

    1 studio citato nel testo non ha un riferimento corrispondente nella monografia (vedi le anomalie nella pagina delle fonti).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver or biliary disorder (HC 2025; EMA 2018; Brinker 2010; ESCOP 2003; McGuffin et al. 1997).

    Fonti citate da Health Canada (6)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2018. European Medicines Agency. European Union herbal monograph on Curcuma longa L., rhizome. London (GB): EMA Committee on Herbal Medicinal Products (HMPC); 25 September 2018. [Accessed 2023 October 14] Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-curcuma-longa-l-rhizoma-revision-1_en.pdf
    • ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.
    • SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications (HC 2025).

    Fonti citate da Health Canada (2)
    • HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
    • SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience any new symptoms including yellowing of the eyes or skin, dark urine, nausea, vomiting, stomach pain (HC 2025).

    Fonti citate da Health Canada (2)
    • HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
    • SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867

    Condizione di applicazione: All uses except for Source of antioxidants and Hepatoprotectant.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Monografia di Health Canada del 26 settembre 2025

    Turmeric -CURCUMA LONGA - Topical

    Precauzioni e avvertenze

    For external use only.

    When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.

    Controindicazioni

    Do not use on deep or puncture wounds, animal bites or serious burns.

    Monografia di Health Canada del 28 febbraio 2025

Riguardano l'ingrediente, non questo prodotto né la sua dose. Non sostituiscono il parere medico.

La data della prova di questo elenco di ingredienti è sconosciuta.

Il prodotto è cambiato? Fotografi la confezione.

Un'informazione inesatta o più recente su questo prodotto, che lei sia lettore o marca? Scriva a contact@compoatlas.com: ogni correzione è pubblicata nel registro delle correzioni.

Invio per analizzare, Maiusc+Invio per una nuova riga